Artivion (AORT) vs Alpha Tau Medical (DRTS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Alpha Tau Medical (DRTS) has outperformed Artivion (AORT) over the past year, gaining 207.7% versus a loss of 59.8%. Over five years, DRTS leads with a +18.5% price change compared with -0.8% for AORT. Alpha Tau Medical is the larger company by market cap ($1.09 billion vs $886.0 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AORT | DRTS |
|---|---|---|
| Share price | $18.16 | $11.76 |
| Market cap | $886.02M | $1.09B |
| 1-day change | -2.00% | +3.93% |
| YTD return | -60.18% | +137.47% |
| 1-year return | -59.76% | +207.72% |
| 5-year return | -0.82% | +18.50% |
| Forward P/E | 34.92 | — |
| EPS (TTM) | $-0.36 | $-1.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $441.33M | — |
| Revenue growth (YoY) | +13.59% | — |
| Net income (latest FY) | $9.77M | $-42.63M |
| Gross margin | 64.40% | — |
| Operating margin | 7.65% | — |
| Net margin | 2.21% | — |
| 52-week high | $48.25 | $15.79 |
| 52-week low | $18.12 | $3.65 |
| Distance from 52-week high | -62.36% | -25.55% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +111.84% | +75.24% |
| Average volume | 671.97K | 591.88K |
| Shares outstanding | 48.79M | 92.48M |
| Employees | 1,800 | 121 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DRTS has outperformed AORT by 267.5 percentage points over the past year.
About Artivion
AORT stock →Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide.
Health Care · Medical/Dental Instruments · 1,800 employees
About Alpha Tau Medical
DRTS stock →Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors.
Health Care · Medical/Dental Instruments · 121 employees
AORT vs DRTS FAQ
Which is bigger, Artivion or Alpha Tau Medical?
Alpha Tau Medical (DRTS) is larger, with a market capitalization of $1.09B compared with $886.02M for Artivion (AORT).
Which stock has performed better over the past year, AORT or DRTS?
DRTS returned +207.72% over the past 12 months, compared with -59.76% for AORT (price return, excluding dividends). Past performance does not predict future results.
Are Artivion and Alpha Tau Medical in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.